Detalhe da pesquisa
1.
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
Nephrol Dial Transplant
; 35(6): 1002-1009, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30418652
2.
Low-dose rituximab is poorly effective in patients with primary membranous nephropathy.
Nephrol Dial Transplant
; 32(10): 1691-1696, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27387472
3.
PTPN22 R620W polymorphism in the ANCA-associated vasculitides.
Rheumatology (Oxford)
; 51(5): 805-12, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237046
4.
[Possible vaccine-induced immune thrombotic thrombocytopenia in a patient with diabetes and chronic kidney disease or random association?]
G Ital Nefrol
; 39(6)2022 Dec 21.
Artigo
em Italiano
| MEDLINE | ID: mdl-36655834
5.
Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey.
Sarcoidosis Vasc Diffuse Lung Dis
; 38(3): e2021017, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34744417
6.
Validation of QB stress test as a useful tool in the detection of native arteriovenous fistula stenosis: results after 22 months of follow-up.
Nephrol Dial Transplant
; 25(6): 1943-9, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064952
7.
[Treatment and monitoring of membranous glomerulonephritis: between past and future]. / Trattamento e monitoraggio della glomerulonefrite membranosa: tra passato e futuro.
G Ital Nefrol
; 28(6): 577, 2011.
Artigo
em Italiano
| MEDLINE | ID: mdl-22167604
8.
Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region.
J Nephrol
; 29(5): 673-81, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26715394
9.
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Autoimmun Rev
; 15(2): 146-54, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527329
10.
Is it the agent or the blood pressure level that matters for renal and vascular protection in chronic nephropathies?
Kidney Int Suppl
; (93): S15-9, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15613061
11.
Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Am J Kidney Dis
; 42(6): 1154-63, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14655186
12.
Hypertension in dialysis: pathophysiology and treatment.
J Nephrol
; 15(4): 438-45, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12243377
13.
Lanthanum carbonate (Shire).
IDrugs
; 6(7): 688-95, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12861474
14.
Intravenous versus subcutaneous EPO: is the cost benefit acceptable?
Am J Kidney Dis
; 41(5): 1122; author reply 1122, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12722048
15.
The role of dialysis in contrast-induced nephropathy: doubts and certainties.
J Cardiovasc Med (Hagerstown)
; 8(8): 549-57, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17667024
16.
The epidemiology of end-stage renal disease in Iran in an international perspective.
Nephrol Dial Transplant
; 17(1): 28-32, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11773458
17.
Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies?
J Am Soc Nephrol
; 13 Suppl 3: S196-201, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12466314
18.
Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease.
J Am Soc Nephrol
; 12(11): 2411-2417, 2001 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11675417